EUROPEAN RESPIRATORY SOCIETY - Switzerland 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:700-800
Total Number of Projects:900-1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:900-1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2008
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 15
As coordinator: 0
As participant: 12
Sole participant: 3
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 132.929.872 850.125 3
2020 1.710.270 26.503.556 2.416.801 1 3
2019 0 50.842.291 572.042 3
2016 1.132.800 2.325.545 1.132.800 1 1
2014 0 23.992.375 284.840 1
2013 729.926 0 729.926 1
2011 0 11.713.194 112.680 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
EUROPEAN LUNG FOUNDATION7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
UNIVERSITY OF SOUTHAMPTON4
ACADEMIC MEDICAL CENTRE AMSTERDAM3
ACADEMISCH ZIEKENHUIS GRONINGEN3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT3
JANSSEN PHARMACEUTICA NV3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
LUNGS EUROPE3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITEIT ANTWERPEN3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF CAMBRIDGE3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ASTRAZENECA2
BERRY CONSULTANTS LLP2
BIOMAX INFORMATICS2
BIOMERIEUX2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING2
EUROPEAN SOCIETY CLINICAL MICROBIOLOGY INFECTIOUS DISEASES2
F HOFFMANNLA ROCHE2
FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS2
KAROLINSKA INSTITUTE2
KING'S COLLEGE LONDON2
KLINIKUM DER UNIVERSITAET ZU KOELN2
OWLSTONE MEDICAL LIMITED2
PFIZER LIMITED2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
SERVICIO ANDALUZ DE SALUD2
THE QUEEN'S UNIVERSITY OF BELFAST2
THE UNIVERSITY OF LIVERPOOL2
THE UNIVERSITY OF MANCHESTER2
THE UNIVERSITY OF NOTTINGHAM2
UNIVERSITA DEGLI STUDI DI CATANIA2
UNIVERSITA DEGLI STUDI DI VERONA2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITY COLLEGE DUBLIN2
UNIVERSITY OF LEICESTER2
UPPSALA UNIVERSITET2
ABBOTT RAPID DX INTERNATIONAL LIMITED1
ABBVIE INC1
ACCELERATE DIAGNOSTICS SL1
AEROGEN1
ALACRIS THERANOSTICS1
AMGEN1
ANSYS FRANCE SAS1
ANSYS GERMANY1
ANSYS UK LIMITED1
ARTTIC INNOVATION1
ASOCIATA AER PUR ROMANIA1
ASSOCIATION EISBM1
ATRYS HEALTH1
AZIENDA OSPEDALE UNIVERSITA PADOVA1
AZIENDA OSPEDALIEROUNIVERSITARIA ANNA MEYER1
AZIENDA UNITA SANITARIA LOCALE DI REGGIO EMILIA1
BAYER1
BD SWITZERLAND SARL1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BIOCARTIS NV1
BIORAD1
BIOSCI CONSULTING1
BIOSCI CONSULTING BVBA1
CAPNETZ STIFTUNG1
CARTANA AB1
CDISC EUROPE FOUNDATION FONDATION1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CENTRE DE REGULACIO GENOMICA1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY1
CENTRE HOSPITALIER UNIVERSITAIRE DE LIEGE1
CENTRE HOSPITALIER UNIVERSITAIRE DE LIMOGES1
CENTRE HOSPITALIER UNIVERSITAIRE DE NICE1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
CLINIQUES UNIVERSITAIRES SAINTLUC1
COMMA SOFT1
COMUNICARE SOLUTIONS1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CRITICAL PATH INSTITUTE LIMITED1
DEPARTMENT OF HEALTH1
DEUTSCHE KREBSGESELLSCHAFT EV1
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG1
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN1
DEUTSCHES ZENTRUM FUR INFEKTIONSFORSCHUNG EV1
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV1
DOHANYZAS VAGY EGESZSEG MAGYAR ALAPITVANY1
DRESDEN UNIVERSITY OF TECHNOLOGY1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
EPITHELIX SARL1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPEAN CANCER PATIENT COALITION1

Constancy:

Total number of partners: 321
Partner loyalty:
Frequent Partner: (> 2 projects): 61
Rare Partner: 260
Frequent / Rare Partner Ratio: 0.23

Project overview:

Start dateProjectacronymrolefundingpartners
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99739
2021-06-01ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS UNITE4TBparticipant92.500.00032
2021-03-01European Clinical Research Alliance on Infectious Diseases ECRAID-Baseparticipant29.969.87521
2020-10-01The RapiD and SecuRe AI enhAnced DiaGnosis, Precision Medicine and Patient EmpOwerment Centered Decision Support System for Coronavirus PaNdemics DRAGONparticipant11.381.97019
2020-07-01REspiratory Science Promoted by International Research Exchanges 4 RESPIRE4coordinator1.710.2701
2020-01-01FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA FAIRparticipant10.162.90415
2020-01-01Discovering the cellular landscape of the airways and the lung discovAIRparticipant4.958.68318
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-04-01The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use VALUE-Dxparticipant6.799.10026
2019-01-01BETTER TREATMENTS FOR BREATHLESSNESS IN PALLIATIVE AND END OF LIFE CARE BETTER-Bparticipant3.770.00013
2016-09-01REspiratory Science Promoted by International Research Exchanges 3 RESPIRE 3coordinator1.132.8001
2016-01-01European Regulatory Science on Tobacco:Policy implementation to reduce lung diseases EUREST-PLUSparticipant2.325.54513
2014-02-01Platform foR European Preparedness Against (Re-)emerging Epidemics PREPAREparticipant23.992.37527
2013-07-01REspiratory Science Promoted by International Research Exchanges 2 RESPIRE 2coordinator729.9261
2011-03-01Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling AirPROMparticipant11.713.19440

Alias institution names:

  • EUROPEAN RESPIRATORY SOCIETY